CD&R and McKesson will acquire Option Care Health for $32.05 per share, valuing the at-home infusion therapy provider at about $5.8 billion. The deal is expected to close in the first half of 2027.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.
